Gabapentin
NDC 16571-226, Gabapentin, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-226
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217995
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN600 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-226-01 | 16571022601 | 100 TABLET in 1 BOTTLE (16571-226-01) |
| 16571-226-50 | 16571022650 | 500 TABLET in 1 BOTTLE (16571-226-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8215da86-d7af-4980-b6d6-4bd46f6bfeafNADAC price for package 16571022601
GET /v1/drugs/nadac/16571022601NADAC price for package 16571022650
GET /v1/drugs/nadac/16571022650
Use it
Look up 16571-226 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-226. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.